The global lentiviral vector CDMO market is projected to grow at a CAGR of 8% over the next five years. This growth is driven by rising demand for gene and cell therapies, an expanding pipeline of ...
Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow ...
PSN Manufacturing achieves ISO 9001:2015 and ISO 13485:2016 certifications, strengthening quality and advancing CDMO vision Erie, PA — PSN PSN Manufacturing says it has achieved ISO 9001:2015 and ISO ...
FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced that it has been named a 2026 CDMO ...
According to a latest market analysis by Future Market Insights, the global CMO/CDMO market is witnessing consistent ...
Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that mAbxience has selected the Genedata Bioprocess ® enterprise ...
The CDMO industry is undergoing a fundamental transformation, driven by the growing complexity of new drug modalities ...
A tough biotech funding environment and a downturn in COVID-related contracts has weighed heavily on CDMOs of all stripes in recent years. Now, with a new CEO waiting in the wings, Swiss manufacturing ...
The pharmaceutical industry has undergone significant evolution within the past few decades, most notably within the past 10-15 years. Specifically, recently extremely relevant biopharmaceutical ...
The license, which Innovent’s Altruist business said is the first of its kind, positions the CDMO to support commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results